CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CHARLES RIVER LABORATORIES INTERNATIONAL, INC. for February 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Payment of Exercise | F | 282.98 | 322 | 91,120 | 29,060 | 29.4 K to 29.1 K (-1.10 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Option Exercise | M | 88.05 | 24,009 | 2,113,992 | 0 | |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 289.02 | 255 | 73,700 | 221,151 | 221.4 K to 221.2 K (-0.12 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 288.33 | 2,466 | 711,029 | 221,406 | 223.9 K to 221.4 K (-1.10 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 287.58 | 2,752 | 791,427 | 223,872 | 226.6 K to 223.9 K (-1.21 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 286.45 | 4,485 | 1,284,744 | 226,624 | 231.1 K to 226.6 K (-1.94 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 285.48 | 1,993 | 568,955 | 231,109 | 233.1 K to 231.1 K (-0.85 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 284.63 | 2,646 | 753,138 | 233,102 | 235.7 K to 233.1 K (-1.12 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 283.53 | 2,278 | 645,890 | 235,748 | 238 K to 235.7 K (-0.96 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 282.49 | 2,656 | 750,280 | 238,026 | 240.7 K to 238 K (-1.10 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 281.65 | 2,191 | 617,096 | 240,682 | 242.9 K to 240.7 K (-0.90 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 280.41 | 1,234 | 346,028 | 242,873 | 244.1 K to 242.9 K (-0.51 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 279.51 | 1,053 | 294,320 | 244,107 | 245.2 K to 244.1 K (-0.43 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Buy | M | 88.05 | 24,009 | 2,113,992 | 245,160 | 221.2 K to 245.2 K (+10.86 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 282.98 | 2,210 | 625,386 | 221,151 | 223.4 K to 221.2 K (-0.99 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 282.98 | 322 | 91,120 | 17,246 | 17.6 K to 17.2 K (-1.83 %) |
Feb 25 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 282.98 | 289 | 81,781 | 16,862 | 17.2 K to 16.9 K (-1.69 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Payment of Exercise | F | 283.59 | 315 | 89,331 | 5,297 | 5.6 K to 5.3 K (-5.61 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Payment of Exercise | F | 289.55 | 287 | 83,101 | 5,612 | 5.9 K to 5.6 K (-4.87 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Gift | G | 0.00 | 7,154 | 0 | 16,975 | 9.8 K to 17 K (+72.84 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Gift | G | 0.00 | 7,154 | 0 | 5,899 | 13.1 K to 5.9 K (-54.81 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Option Exercise | M | 109.34 | 20,295 | 2,219,055 | 20,296 | |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Option Exercise | M | 144.67 | 17,436 | 2,522,466 | 34,872 | |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 282.78 | 984 | 278,255 | 223,361 | 224.3 K to 223.4 K (-0.44 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 281.91 | 2,832 | 798,358 | 224,345 | 227.2 K to 224.3 K (-1.25 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 280.96 | 4,259 | 1,196,590 | 227,177 | 231.4 K to 227.2 K (-1.84 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 279.97 | 6,474 | 1,812,519 | 231,436 | 237.9 K to 231.4 K (-2.72 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 279.31 | 925 | 258,366 | 237,910 | 238.8 K to 237.9 K (-0.39 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 278.07 | 1,249 | 347,310 | 238,835 | 240.1 K to 238.8 K (-0.52 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 277.00 | 1,809 | 501,095 | 240,084 | 241.9 K to 240.1 K (-0.75 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 276.03 | 1,309 | 361,323 | 241,893 | 243.2 K to 241.9 K (-0.54 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 274.81 | 454 | 124,762 | 243,202 | 243.7 K to 243.2 K (-0.19 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Buy | M | 109.34 | 20,295 | 2,219,055 | 243,656 | 223.4 K to 243.7 K (+9.09 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 283.59 | 1,994 | 565,478 | 223,361 | 225.4 K to 223.4 K (-0.88 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 289.55 | 1,814 | 525,244 | 225,355 | 227.2 K to 225.4 K (-0.80 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 285.79 | 52 | 14,861 | 227,169 | 227.2 K to 227.2 K (-0.02 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 284.50 | 4,240 | 1,206,283 | 227,221 | 231.5 K to 227.2 K (-1.83 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 283.56 | 4,020 | 1,139,911 | 231,461 | 235.5 K to 231.5 K (-1.71 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 282.49 | 5,476 | 1,546,929 | 235,481 | 241 K to 235.5 K (-2.27 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 281.69 | 2,223 | 626,190 | 240,957 | 243.2 K to 241 K (-0.91 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 280.66 | 1,425 | 399,944 | 243,180 | 244.6 K to 243.2 K (-0.58 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Buy | M | 144.67 | 17,436 | 2,522,466 | 244,605 | 227.2 K to 244.6 K (+7.68 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Option Exercise | M | 52.29 | 3,530 | 184,584 | 0 | |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Sell | S | 281.66 | 658 | 185,330 | 40,529 | 41.2 K to 40.5 K (-1.60 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | CHUBB STEPHEN D | Director | Buy | M | 52.29 | 3,530 | 184,584 | 41,187 | 37.7 K to 41.2 K (+9.37 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 283.59 | 315 | 89,331 | 17,568 | 17.9 K to 17.6 K (-1.76 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 289.55 | 317 | 91,787 | 17,883 | 18.2 K to 17.9 K (-1.74 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 283.59 | 315 | 89,331 | 17,568 | 17.9 K to 17.6 K (-1.76 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 289.55 | 317 | 91,787 | 17,883 | 18.2 K to 17.9 K (-1.74 %) |
Feb 24 2021 | CRL | CHARLES RIVER LABO ... | Creamer Victoria L | EVP & Chief People ... | Payment of Exercise | F | 289.55 | 121 | 35,036 | 5,507 | 5.6 K to 5.5 K (-2.15 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Option Exercise | M | 73.70 | 1,675 | 123,448 | 0 | |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Payment of Exercise | F | 283.59 | 315 | 89,331 | 29,382 | 29.7 K to 29.4 K (-1.06 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Payment of Exercise | F | 289.55 | 308 | 89,181 | 29,697 | 30 K to 29.7 K (-1.03 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Sell | S | 293.92 | 1,675 | 492,311 | 30,005 | 31.7 K to 30 K (-5.29 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Buy | M | 73.70 | 1,675 | 123,448 | 31,680 | 30 K to 31.7 K (+5.58 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Payment of Exercise | F | 283.59 | 84 | 23,822 | 4,052 | 4.1 K to 4.1 K (-2.03 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Payment of Exercise | F | 289.55 | 62 | 17,952 | 4,136 | 4.2 K to 4.1 K (-1.48 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Sell | S | 290.99 | 410 | 119,305 | 4,198 | 4.6 K to 4.2 K (-8.90 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 283.59 | 272 | 77,136 | 17,031 | 17.3 K to 17 K (-1.57 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 289.55 | 247 | 71,519 | 17,303 | 17.6 K to 17.3 K (-1.41 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 292.37 | 1,149 | 335,937 | 0 | 1.1 K to 0 (-100.00 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 291.83 | 1,400 | 408,558 | 1,149 | 2.5 K to 1.1 K (-54.92 %) |
Feb 23 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Sell | S | 290.03 | 6,107 | 1,771,191 | 2,549 | 8.7 K to 2.5 K (-70.55 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 289.16 | 31 | 8,964 | 227,169 | 227.2 K to 227.2 K (-0.01 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 287.99 | 2,402 | 691,753 | 227,200 | 229.6 K to 227.2 K (-1.05 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 287.18 | 4,775 | 1,371,289 | 229,602 | 234.4 K to 229.6 K (-2.04 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 286.48 | 2,490 | 713,343 | 234,377 | 236.9 K to 234.4 K (-1.05 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 285.15 | 9,643 | 2,749,723 | 236,867 | 246.5 K to 236.9 K (-3.91 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 284.21 | 4,038 | 1,147,634 | 246,510 | 250.5 K to 246.5 K (-1.61 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 282.96 | 727 | 205,714 | 250,548 | 251.3 K to 250.5 K (-0.29 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 282.39 | 3,766 | 1,063,485 | 251,275 | 255 K to 251.3 K (-1.48 %) |
Feb 16 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Sell | S | 281.32 | 2,128 | 598,652 | 255,041 | 257.2 K to 255 K (-0.83 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 260.88 | 4,708 | 1,228,223 | 18,200 | 22.9 K to 18.2 K (-20.55 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Payment of Exercise | F | 260.88 | 4,708 | 1,228,223 | 18,200 | 22.9 K to 18.2 K (-20.55 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Grant | A | 0.00 | 11,862 | 0 | 22,908 | 11 K to 22.9 K (+107.39 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Grant | A | 0.00 | 11,862 | 0 | 22,908 | 11 K to 22.9 K (+107.39 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Gift | G | 0.00 | 310 | 0 | 11,046 | 11.4 K to 11 K (-2.73 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | LaPlume Joseph W | EVP, Corp Strategy ... | Gift | G | 0.00 | 310 | 0 | 11,046 | 11.4 K to 11 K (-2.73 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Creamer Victoria L | EVP & Chief People ... | Payment of Exercise | F | 259.05 | 251 | 65,022 | 5,628 | 5.9 K to 5.6 K (-4.27 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Creamer Victoria L | EVP & Chief People ... | Payment of Exercise | F | 259.05 | 251 | 65,022 | 5,628 | 5.9 K to 5.6 K (-4.27 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Payment of Exercise | F | 260.88 | 953 | 248,619 | 4,608 | 5.6 K to 4.6 K (-17.14 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Knell Michael Gunnar | CSVP&Chief Accounti ... | Grant | A | 0.00 | 3,162 | 0 | 5,561 | 2.4 K to 5.6 K (+131.80 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Payment of Exercise | F | 260.88 | 4,709 | 1,228,484 | 30,005 | 34.7 K to 30 K (-13.57 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Girshick Birgit | Corporate Executive ... | Grant | A | 0.00 | 11,862 | 0 | 34,714 | 22.9 K to 34.7 K (+51.91 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Payment of Exercise | F | 260.88 | 32,753 | 8,544,603 | 257,169 | 289.9 K to 257.2 K (-11.30 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Grant | A | 0.00 | 75,129 | 0 | 289,922 | 214.8 K to 289.9 K (+34.98 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Gift | G | 0.00 | 3,500 | 0 | 214,793 | 218.3 K to 214.8 K (-1.60 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | FOSTER JAMES C | Chairman, President ... | Gift | G | 0.00 | 4,706 | 0 | 0 | 4.7 K to 0 (-100.00 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Payment of Exercise | F | 260.88 | 3,795 | 990,040 | 17,550 | 21.3 K to 17.6 K (-17.78 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Grant | A | 0.00 | 14,234 | 0 | 21,345 | 7.1 K to 21.3 K (+200.17 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Gift | G | 0.00 | 8,656 | 0 | 8,656 | 0 to 8.7 K |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Smith David Ross | Corporate Executive ... | Gift | G | 0.00 | 8,656 | 0 | 7,111 | 15.8 K to 7.1 K (-54.90 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Payment of Exercise | F | 260.88 | 4,708 | 1,228,223 | 13,053 | 17.8 K to 13.1 K (-26.51 %) |
Feb 02 2021 | CRL | CHARLES RIVER LABO ... | Barbo William D | Corporate Executive ... | Grant | A | 0.00 | 11,862 | 0 | 17,761 | 5.9 K to 17.8 K (+201.08 %) |